+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cilastatin"

Carbapenem-based Antibiotics Global Market Report 2024 - Product Thumbnail Image

Carbapenem-based Antibiotics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Antibiotic Drug Resistance. Edition No. 1 - Product Thumbnail Image

Antibiotic Drug Resistance. Edition No. 1

  • Book
  • October 2019
  • 720 Pages
  • 8 Results (Page 1 of 1)
Loading Indicator

Cilastatin is an antibiotic used in combination with other antibiotics to treat a variety of bacterial infections. It is a prodrug, meaning it is inactive until it is metabolized in the body. Cilastatin is used in combination with imipenem to treat serious infections caused by susceptible bacteria. It is also used to reduce the risk of kidney damage caused by imipenem. Cilastatin is available in both oral and intravenous formulations. Cilastatin is used in combination with other antibiotics to treat a variety of bacterial infections, including pneumonia, urinary tract infections, and skin and soft tissue infections. It is also used to reduce the risk of kidney damage caused by imipenem. Cilastatin is generally well tolerated, with the most common side effects being nausea, vomiting, and diarrhea. The cilastatin market is a niche market, with a limited number of manufacturers. Some of the companies in the market include Merck & Co., Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd. Show Less Read more